Troner, M <br/><br/>
Phase III comparison of cisplatin alone versus cisplatin, doxorubicin and cyclophosphamide in the treatment of bladder (urothelial) cancer: a Southeastern Cancer Study Group trial.  [electronic resource] 

 -  The Journal of urology  Apr 1987 
 - 660-2 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0022-5347 
<br/><br/><label>Standard No.: </label>10.1016/s0022-5347(17)44167-x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Carcinoma, Transitional Cell--drug therapy<br/>Cisplatin--administration & dosage<br/>Clinical Trials as Topic<br/>Cyclophosphamide--administration & dosage<br/>Doxorubicin--administration & dosage<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Prospective Studies<br/>Random Allocation<br/>Urinary Bladder Neoplasms--drug therapy